Board MeetingOutcome of Board Meeting
Morepen Labs approved consolidated financial results for FY26 with a net profit of Rs 94.88 Cr.
Morepen Laboratories LimitedMOREPENLAB · Filed with the exchange
A final dividend of Re 0.20/share was proposed.
The board also approved a revised agreement to hive off its Medical Devices business to a subsidiary for Rs 197.10 Cr and re-appointed Cost Auditors.
No comments yet. Be the first.